All stocks Β· VIVANZA
VB

Vivanza Biosciences Limited

VIVANZA BSE Drug Manufacturers - Specialty & Generic Healthcare

Vivanza Biosciences Limited engages in the manufacturing and sale of pharmaceutical products in India. It offers pharmaceuticals in various categories; injectable products, including antifungals, antibiotics, antivirals…

ISIN INE984E01035
Listed β€”
Quarters tracked 13
Filings 19 docs

About

Vivanza Biosciences Limited engages in the manufacturing and sale of pharmaceutical products in India. It offers pharmaceuticals in various categories; injectable products, including antifungals, antibiotics, antivirals, and other products for hospital and clinical use; Vivanza medical gloves for medical and surgical use; therapeutic index injection; and veterinary products and feed. The company was incorporated in 1982 and is headquartered in Ahmedabad, India.

Key Metrics

as of Sep 2026
Market Cap7 Cr
P/E15.20
Div Yield0.00 %
Book Valueβ‚Ή1.09
52w Highβ‚Ή2.72
52w Lowβ‚Ή1.52
Face Valueβ‚Ή1.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 9.29 6.36 45.25 55.36 8.94 0.48 1.50 3.00 2.44 4.42 6.56 7.62 9.23
Expenses 9.36 6.59 45.04 54.75 8.79 1.44 1.37 2.89 2.08 4.56 6.27 7.30 8.64
Operating Profit -0.07 -0.23 0.21 0.61 0.15 -0.96 0.13 0.11 0.36 -0.14 0.29 0.32 0.59
OPM % -0.75 -3.62 0.46 1.10 1.68 -200.00 8.67 3.67 14.75 -3.17 4.42 4.20 6.39
Other Income 0.37 0.01 0.08 0.01 0.02 0.05 0.01 0.00 0.00 -0.03 0.02 0.05 0.01
Depreciation 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00
Interest 0.11 0.07 0.09 0.05 0.08 0.08 0.09 0.09 0.09 0.09 0.10 0.11 0.11
Profit before tax 0.18 -0.30 0.20 0.57 0.09 -0.99 0.05 0.02 0.27 -0.27 0.21 0.26 0.49
Tax % 22.22 50.00 0.00 0.00 0.00 1.01 0.00 0.00 0.00 55.56 0.00 0.00 0.00
Net Profit 0.15 -0.45 0.20 0.56 0.09 -1.00 0.04 0.02 0.27 -0.41 0.21 0.26 0.49
EPS in Rs 0.04 -0.11 0.05 0.14 0.02 -0.25 0.01 0.00 0.07 -0.10 0.05 0.06 0.12

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Sales 116.007.0028.0018.0010.0010.0010.003.006.003.000.00
Expenses 115.008.0027.0017.0010.0010.0010.003.006.004.000.00
Operating Profit 1.000.001.001.000.000.000.000.001.000.000.00
OPM % 0.60-4.903.903.80-0.600.90-3.60-0.809.00-9.00β€”
Other Income 0.000.000.000.001.001.001.000.000.000.000.00
Interest 0.000.000.000.000.000.000.000.000.000.000.00
Depreciation 0.000.000.000.000.000.000.000.000.000.000.00
Profit before tax 1.00-1.001.001.000.000.000.000.000.000.000.00
Tax % 27.002.0021.0017.000.0042.000.000.0013.000.000.00
Net Profit 0.00-1.001.001.000.000.000.000.000.000.000.00
EPS in Rs 0.10-0.170.140.150.080.02-0.05-0.110.05-0.08-0.32
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Equity Capital 4.004.004.004.004.004.004.004.004.004.000.19
Reserves 0.000.001.000.00-1.00-1.00-1.00-1.000.000.000.00
Borrowings 10.009.005.008.006.000.000.001.001.001.000.00
Other Liabilities 8.004.0010.0010.007.005.009.006.005.003.000.00
Total Liabilities 22.0016.0020.0022.0016.008.0012.0011.0010.007.001.00
Fixed Assets 2.002.002.002.002.002.002.002.002.002.000.00
CWIP 0.000.000.000.000.000.000.000.000.000.000.00
Investments 0.000.000.000.000.000.000.000.000.000.000.00
Other Assets 20.0014.0017.0020.0013.006.0010.009.008.005.001.00
Total Assets 22.0016.0020.0022.0016.008.0012.0011.0010.007.001.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Cash from Operating Activity -3.00-2.002.00-1.002.00-3.003.001.000.00-2.000.00
Cash from Investing Activity 0.000.000.000.000.000.000.000.000.002.000.00
Cash from Financing Activity 3.002.00-2.001.00-2.003.00-3.00-1.00-1.000.000.00
Net Cash Flow 0.000.000.000.000.000.000.000.00-1.000.000.00
Free Cash Flow -3.00-3.002.00-1.002.00-3.003.001.000.00-2.000.00
CFO/OP % -328.00692.00203.00-124.00-4,117.00-3,367.00-876.00-4,300.00-15.00668.000.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Debtor Days 39.00398.00151.00256.00275.00231.00250.00782.00287.00267.00
Inventory Days 11.00121.0028.0055.0092.0026.0038.00309.00150.00215.00
Days Payable 23.00140.00116.00211.00207.00154.00319.00878.00319.00304.00
Cash Conversion Cycle 27.00379.0064.0099.00160.00103.00-32.00213.00118.00178.00
Working Capital Days 7.00154.0044.0050.00103.00104.00109.00469.00237.00332.00
ROCE % 6.00-3.0010.0011.0012.0017.006.000.0013.00-10.00

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 20.02 20.02 20.02 20.02 20.02 20.02 20.02 39.86 40.05 43.24 44.90 47.29
Public 79.98 79.98 79.98 79.98 79.98 79.98 79.98 60.13 59.95 56.75 55.10 52.70
No. of Shareholders 19,254 19,461 19,822 20,170 20,458 20,833 20,635 16,701 16,941 6,992 5,937 5,039

Corporate Actions

2 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Split 24 Mar 2023 24 Mar 2023 10:1 β€”
Other 27 May 2015 28 May 2015 β€” β€” Reduction of Capital

Announcements

5 filings